A new imaging system for studying cancer in small animals
The Super Argus PET/CT 6R for Pre-clinical Oncology Research
This study is all about getting a new, advanced scanner to help scientists at Memorial Sloan Kettering Cancer Center better understand how cancer grows and responds to treatments in mice and rats, which could lead to better therapies for people with cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10852626 on NIH RePORTER |
What this research studies
This research focuses on acquiring a state-of-the-art Super Argus PET/CT 6R scanner to enhance pre-clinical oncology research. The scanner will be used to monitor cancer progression and treatment responses in mouse and rat models, allowing researchers to non-invasively assess the effectiveness of new cancer therapies. By evaluating how cancer and immune cells behave and respond to treatments, this research aims to improve our understanding of cancer biology and therapeutic interventions. The facility will serve as a vital resource for ongoing cancer research at Memorial Sloan Kettering Cancer Center.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals with cancer or those interested in the biological mechanisms of cancer treatment.
Not a fit: Patients who are not involved in pre-clinical research or do not have a cancer diagnosis may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments by providing insights into how therapies work at the cellular level.
How similar studies have performed: Other research has successfully utilized advanced imaging technologies in pre-clinical oncology, indicating a strong potential for this approach.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Zanzonico, Pat B — Sloan-Kettering Inst Can Research
- Study coordinator: Zanzonico, Pat B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.